Dapagliflozin Adverse Reaction: Clinical Trials

2 trials for Dapagliflozin Adverse Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Unknown 1

Follow Dapagliflozin Adverse Reaction: new trials by email Literature Review of Dapagliflozin Adverse Reaction trials Research Report on Dapagliflozin Adverse Reaction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes
Dapagliflozin 10mg Tab, Metformin 1000 mg (ttd), Placebo - Obesity, Dapagliflozin Adverse Reaction
Phase 4Active not recruitingOman Ministry of Health1502024-04-222025-03-26
Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE)
Dapagliflozin 10mg Tab - Dapagliflozin Adverse Reaction, Efficacy
Phase 4UnknownMonaldi Hospital502022-08-012023-02-08

Narrower conditions

Heart Failure (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Body Weight (1)  ·  Body Weight Changes (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

dapagliflozin (2)  ·  Disulfiram (1)  ·  Metformin (1)

Sponsors

Monaldi Hospital (1)  ·  Oman Ministry of Health (1)

Countries

Italy (1)  ·  Oman (1)

Top investigators

Thuraiya Al Harthi, Masters (1)

Results publications

PMID 38430085